КОМПЛЕКСНОЕ ЛЕЧЕНИЕ БРОНХИАЛЬНОЙ АСТМЫ У ДЕТЕЙ С ИСПОЛЬЗОВАНИЕМ РЕЗИСТОЛА

Аннотация

Нами обследовано, 78 детей с различной степенью тяжести бронхиальной астмы в возрасте от 6-14 лет. Первая группа больных, получавшие стандартную базисную терапию и таблетку плацебо (n=35); вторая группа больных (n=43), получавшие наряду с аналогичным спектром базисной терапии был назначен препарат «Резистол» по схеме. Комбинированное использование противовоспалительных препаратов и Резистола дает выраженный эффект в плане улучшения клинического состояния детей, нормализации иммунологических, лимфоцитарных показателей у больных бронхиальной астмой. Ключевые слова: бронхиальная астма у детей, иммунология, Резистол. Ganiev Abdurashid Ganievich Associate Professor, Department of Hospital Pediatrics, Andijan State Medical Institute. Andijan, Uzbekistan Nazarov Komil Dadaevich associate professor of the department of hospital pediatrics, Urgench branch of the Tashkent Medical Academy. Urgench, Uzbekistan COMPREHENSIVE TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN USING RESISTOL ANNOTATION We examined 78 children with varying degrees of severity of bronchial asthma at the age of 6-14 years. The first group of patients who received standard basic therapy and a placebo pill (n = 35); the second group of patients (n = 43), who received along with a similar spectrum of basic therapy, was prescribed the drug "Resistol" according to the scheme. The combined use of anti-inflammatory drugs and Resistol gives a pronounced effect in terms of improving the clinical condition of children, normalizing immunological and lymphocytic parameters in patients with bronchial asthma. Keywords: bronchial asthma in children, immunology, Resistol. Ganiev Abdurashid Ganievich Andijon davlat tibbiyot instituti gospital pediatriya kafedrasi dotsenti. Andijon, O'zbekiston Nazarov Komil Dadaevich Toshkent tibbiyot akademiyasining Urganch filiali, gospital pediatriya kafedrasi dotsenti. Urganch, O'zbekiston BRONXIАL АSTMАNI KOPLEKS DАVOLАSHDА REZISTOL MODDАSINI QO’LLАSH USULI 55 ЖУРНАЛ КАРДИОРЕСПИРАТОРНЫХ ИССЛЕДОВАНИЙ | JOURNAL OF CARDIORESPIRATORY RESEARCH №3 | 2020 ANNOTATSIYA Biz 6-14 yoshda bronxial astmaning og'irligi har xil bo'lgan 78 bolani tekshirdik. Standart terapiya asosida platsebo tabletkasini olgan bemorlarning birinchi guruh deb atadik (n = 35); shunga o'xshash asosiy terapiya spektri bilan birga qabul qilingan bemorlarning ikkinchi guruhiga (n = 43) sxema bo'yicha "Resistol" preparati buyurildi. Yallig'lanishga qarshi vositalar va Resistolni birgalikda qo'llash bolalarning klinik holatini yaxshilash, bronxial astma bilan og'rigan bemorlarda immunologik, limfotsitik ko'rsatkichlarni normallashtirish nuqtai nazaridan sezilarli ta'sir ko'rsatadi. Kalit soʼzlar: bolalarda bronxial astma, immunologiya, rezistol. The problem of asthma continues to be relevant throughout the Materials and methods: Under our supervision in the world, despite numerous studies and a sufficient amount of treatment clinic of the department of hospital, polyclinic and emergency and preventive measures. In childhood, bronchial asthma is one of the treatment of the Andijan State Medical Institute based on ODMMTS most common chronic diseases [1, 2, 4, 9]. Andijan there were 78 children with varying degrees of severity of According to the results of a number of researchers, the bronchial asthma between the ages of 6-14 years. prevalence of asthma in the Republic of Uzbekistan varies from 3.1% For a prospective study, we formed two groups of patients: the to 8.2%, which is due not only to the influence of external regional first group of patients who received standard basic therapy (n = 35); factors, but also to the use of various diagnostic methods [1]. the second group of patients (n = 43) who received, along with a However, as shown by virtually all studies conducted under the similar range of basic therapy, received the drug Resistol on a five- ISAAC (Intemacional Study of Astma and Allergy in Children) day schedule (1-day 1.0 ml, 2-day 1.5 ml, 3-day 2.0 ml, 4-day 2.5 ml, program in all regions of the planet, the true incidence of asthma was 5-day 3.0 ml. Intramuscularly) with a break of 1 day, 3 times. significantly higher than official statistics [8, 9, 10]. The The duration of "Resistol" therapy was 15 days. The duration of discrepancies between official statistics on recruitment and the results the observation of the patients of the studied groups lasted for a year. of epidemiological studies are also associated with the underdiagnosis In addition to age, the criteria for inclusion in the study group were of bronchial asthma in different age groups. verification of the diagnosis of bronchial asthma, mild, moderate, Analysis of epidemiological studies in the city of Andijan severe disease. The exclusion criteria from the study group were showed that in the structure of the prevalence of allergic diseases, severe for the disease using systemic glucocorticoids for more than 6 bronchial asthma is in 2nd place (5.6 + 0.03%), yielding to allergic months. rhinitis